Filemón Bucardo

Prof. Filemón Bucardo

Universidad Nacional Autónoma de Nicaragua-León, León, Nicaragua
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2015 in Eurosurveillance
Verified
Journal Article
Open access
Miranda de GraafMiranda de Graaf
Miranda de Graaf
JBJ van Beek
J van Beek
HVH Vennema
H Vennema
APA T Podkolzin
A T Podkolzin
JHJoanne Hewitt
Joanne Hewitt
MKMarion P.G. Koopmans
Marion P.G. Koopmans
In the winter of 2014/15 a novel GII.P17-GII.17 norovirus strain (GII.17 Kawasaki 2014) emerged, as a major cause of gastroenteritis outbreaks in China and Japan. Since their emergence these novel GII.P17-GII.17 viruses have replaced the previously dominant GII.4 genotype Sydney 2012 variant in some areas in Asia but were only detected in a limited number of cases on other continents. This perspective provides an overview of the available information on GII.17 viruses in order to gain insight in the viral and host characteristics of this norovirus genotype. We further discuss the emergence of this novel GII.P17-GII.17 norovirus in context of current knowledge on the epidemiology of noroviruses. It remains to be seen if the currently dominant norovirus strain GII.4 Sydney 2012 will be replaced in other parts of the world. Nevertheless, the public health community and surveillance systems need to be prepared in case of a potential increase of norovirus activity in the next seasons caused by this novel GII.P17-GII.17 norovirus.

5 August 2014 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JNJohan Nordgren
Johan Nordgren
SSSumit Sharma
Sumit Sharma
Filemón BucardoFilemón Bucardo
Filemón Bucardo
WNWaqas Nasir
Waqas Nasir
GGGökçe Günaydın
Gökçe Günaydın
Lennart SvenssonLennart Svensson
Lennart Svensson
Background. The live oral rotavirus (RV) vaccines have shown a reduced efficacy in Africa. Recent in vitro studies have shown binding of the RV surface protein (VP4) to histo–blood group antigens (HBGAs) in an RV genotype–dependent manner, suggesting them to be putative receptors for RV. The diversity of HBGA phenotypes in different ethnic populations, combined with prevalence/absence of specific RV genotypes, led us to hypothesize whether the genetic variations in HBGAs in a population limit susceptibility to certain RV genotypes, plausibly leading to reduced vaccine efficacy. Methods. Association between HBGAs status and susceptibility to RV P genotypes was investigated in children in Burkina Faso and Nicaragua. In total, 242 children with diarrhea in Burkina Faso and Nicaragua were investigated, 93 of whom were RV positive. Results. In Burkina Faso, the P[8] RV strains (n = 27) infected only Lewis- and secretor-positive children (27/27; P < .0001), but no Lewis-negative children. In contrast, the P[6] strains (n = 27) infected predominantly Lewis-negative children (n = 18; P < .0001) but also Lewis-positive children, irrespective of their secretor status. The results from Nicaragua confirmed that all P[8]-infected children (n = 22) were secretor Lewis positive. Conclusions. As VP4 of genotype P[8] is a component of current RV vaccines, our finding that Lewis-negative children are resistant to P[8] strains provides a plausible explanation for the reduced vaccine efficacy in populations with a high percentage of Lewis-negative individuals, such as in Africa. Furthermore, our findings provide a plausible explanation as to why P[6] RV strains are more common in Africa.

21 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Filemón BucardoFilemón Bucardo
Filemón Bucardo
YRYaoska Reyes
Yaoska Reyes
LSLennart Svensson
Lennart Svensson
JNJohan Nordgren
Johan Nordgren
Despite significant reduction of rotavirus (RV) infections following implementation of RotaTeq vaccination in Nicaragua, a large burden of patients with diarrhea persists. We conducted a community- and hospital-based study of the burden of RV, norovirus (NV) and sapovirus (SV) infections as cause of sporadic acute gastroenteritis (GE) among 330 children ≤ 5 years of age between September 2009 and October 2010 in two major cities of Nicaragua with a RotaTeq coverage rate of 95%. We found that NV, SV and RV infections altogether accounted for 45% of cases of GE. Notably, NV was found in 24% (79/330) of the children, followed by SV (17%, 57/330) and RV (8%, 25/330). The detection rate in the hospital setting was 27%, 15% and 14% for NV, SV and RV respectively, whereas in the community setting the detection rate of RV was < 1%. Among each of the investigated viruses one particular genogroup or genotype was dominant; GII.4 (82%) for NV, GI (46%) for SV and G1P[8] (64%) in RV. These variants were also found in higher proportions in the hospital setting compared to the community setting. The GII.4.2006 Minerva strain circulating globally since 2006 was the most common among genotyped NV in this study, with the GII.4-2010 New Orleans emerging in 2010. This study shows that NV has become the leading viral cause of gastroenteritis at hospital and community settings in Nicaragua after implementation of RV vaccination.

1 May 2021 in Emerging Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JCJennifer L. Cannon
Jennifer L. Cannon
JBJoseph Bonifacio
Joseph Bonifacio
Filemón BucardoFilemón Bucardo
Filemón Bucardo
JBJavier Buesa
Javier Buesa
LBLeesa Bruggink
Leesa Bruggink
JVJan Vinje
Jan Vinje
Norovirus Genotype Distribution among Children

1 November 2014 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
SBSylvia Becker-Dreps
Sylvia Becker-Dreps
Filemón BucardoFilemón Bucardo
Filemón Bucardo
SVSamuel Vilchez
Samuel Vilchez
LZLuis Enrique Zambrana
Luis Enrique Zambrana
LLLan Liu
Lan Liu
MPMargarita Paniagua
Margarita Paniagua
Background: Nicaragua was the first developing nation to implement routine immunization with the pentavalent rotavirus vaccine (RV5). In this RV5-immunized population, understanding infectious etiologies of childhood diarrhea is necessary to direct diarrhea treatment and prevention efforts. Methods: We followed a population-based sample of children <5 years in León, Nicaragua for diarrhea episodes through household visits. Information was obtained on RV5 history and sociodemographics. Stool samples collected during diarrhea episodes and among healthy children underwent laboratory analysis for viral, bacterial and parasitic enteropathogens. Detection frequency and incidence of each enteropathogen was calculated. Results: The 826 children in the cohort experienced 677 diarrhea episodes during 607.5 child-years of exposure time (1.1 episodes per child-year). At least 1 enteropathogen was detected among 61.1% of the 337 diarrheal stools collected. The most common enteropathogens among diarrheal stools were: norovirus (20.4%), sapovirus (16.6%), enteropathogenic Escherichia coli (11.3%), Entamoeba histolytica/dispar (8.3%), Giardia lamblia (8.0%) and enterotoxigenic E. coli (7.7%), with rotavirus detected among 5.3% of diarrheal stools. Enteropathogenic Escherichia coli and enterotoxigenic E. coli were frequently detected among stools from healthy children. Among children with diarrhea, norovirus was more commonly detected among younger children (< 2 years) and G. lamblia was more commonly detected among older children (2–4 years). The mean age of rotavirus detection was 34.6 months. Conclusions: In this Central American community after RV5 introduction, rotavirus was not commonly detected among children with diarrhea. Prevention and appropriate management of norovirus and sapovirus should be considered to further reduce the burden of diarrheal disease.

1 August 2015 in Virology
Verified
Journal Article
Closed access
Tung PhanTung Phan
Tung Phan
DMDaisuke Mori
Daisuke Mori
XDXutao Deng
Xutao Deng
SRShaman Rajindrajith
Shaman Rajindrajith
URUdaya Ranawaka
Udaya Ranawaka
EDEric Delwart
Eric Delwart